Resverlogix starts Phase IIb oral Covid-19 drug trial
The trial to assess the efficacy and safety of apabetalone will enrol 100 subjects at centres in Canada and Brazil.

The trial to assess the efficacy and safety of apabetalone will enrol 100 subjects at centres in Canada and Brazil.
Centricity Research has more than 40 fully owned and integrated clinical research offices in Canada and the US.
The autonomous, two-phased trial HOPE will be conducted at a Numinus clinic in Vancouver, Canada.
Medicago is seeking Health Canada approval for use of the adjuvant vaccine in healthy adults aged 18 years and above.
In an exclusive, Medicago reveals its booster trial plans, including a tweaked vaccine with similar mutations to the Omicron variant.
ByThe trial will compare and assess GTX-104’s relative bioavailability with the oral nimodipine capsules.
Phase III AURORA 2 clinical trial has assessed the tolerability and safety of Lupkynis to treat LN in patients with…
The trial intends to enrol 100 adult patients hospitalised with Covid-19 at various sites in Brazil and Canada.